you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

BSE Live

May 17, 16:00
2178.95 30.60 (1.42%)
Volume
AVERAGE VOLUME
5-Day
10,553
10-Day
10,567
30-Day
16,352
11,504
  • Prev. Close

    2148.35

  • Open Price

    2132.45

  • Bid Price (Qty.)

    2170.00 (49)

  • Offer Price (Qty.)

    2178.95 (1)

NSE Live

May 17, 15:57
2180.00 31.15 (1.45%)
Volume
AVERAGE VOLUME
5-Day
253,118
10-Day
182,088
30-Day
245,446
301,676
  • Prev. Close

    2148.85

  • Open Price

    2148.85

  • Bid Price (Qty.)

    2180.00 (9)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Ipca Labs

  • May 17, 2021 12:09 Source: BSE

    Ipca Laboratories - Board Meeting Intimation for The Audited Financial Results For The 4Th Quarter And Financial Year Ended 31St March, 2021.

    IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2021 ,inter alia, to consider and approve the Audited Financial Results for the 4th quarter and financial year ended 31st March, 2021.

  • Apr 30, 2021 17:09 Source: BSE

    Ipca Laboratories - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    kindly note that the Company has issued duplicate share certificate(s) to the shareholder, in lieu of the original share certificate misplaced / lost :

  • Apr 30, 2021 16:40 Source: BSE

    Ipca Laboratories - Announcement under Regulation 30 (LODR)-Acquisition

    This is to inform you that the Company has subscribed to partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth Services LLP). The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Clause A(1) of Part A, Schedule III of the aforesaid regulations, is attached as per 'Annexure A'.This is for your information and dissemination.

  • Apr 19, 2021 16:47 Source: BSE

    Ipca Laboratories - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    kindly note that the Company has issued duplicate share certificate(s) to the shareholder, in lieu of the original share certificate misplaced / lost as per attached details:

  • Apr 14, 2021 16:11 Source: BSE

    Ipca Laboratories - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Notice in respect of intimation of loss of equity share certificates

  • Apr 14, 2021 16:04 Source: BSE

    Ipca Laboratories - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

    Sr. No. Particulars Details
    1Name of CompayIPCA LABORATORIES LTD.
    2CINL24239MH1949PLC007837
    3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 272.22
    4Highest Credit Rating during the previous FY AA
    4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED
    5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE


    We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No



    Name of the Company Secretary: Harish Kamath
    Designation: Company Secretary
    EmailId: harish.kamath@ipca.com
    Name of the Chief Financial Officer: A K Jain
    Designation: Jt Managing Director CFO
    EmailId: harish.kamath@ipca.com

    Date: 14/04/2021

    Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

  • Apr 14, 2021 12:42 Source: BSE

    Ipca Laboratories - Certificate Under Regulation 40(9)

    Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a certified copy of the compliance certificate for the period ended March 31, 2021 under Regulation 40(9) issued by M/s. Parikh Parekh & Associates, practicing Company Secretaries.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Feb 04, 2021
Remark : Quarterly Results